Factors influencing circuit lifetime in paediatric continuous kidney replacement therapies – results from the EurAKId registry
Anna Deja, Isabella Guzzo, Andrea Cappoli, Raffaella Labbadia, Aysun Karabay Bayazıt, Dinçer Yıldızdaş, Claus Peter Schmitt, Marcin Tkaczyk, Mirjana Cvetković, Mirjana Kostić, Wesley Hayes, Rukshana Shroff, Augustina Jankauskienė, Ernestas Viršilas, Germana Longo, Enrico Vidal, Sevgı Mır, İpek Kaplan Bulut, Andrea Pasini, Fabio Paglialonga, Giovanni Montini, Ebru Yılmaz, Liane Correia‐Costa, Ana Teixeira, Franz Schaefer, for the ESCAPE Network
Abstract
BACKGROUND: Continuous kidney replacement therapy (CKRT) has recently become the preferred kidney replacement modality for children with acute kidney injury (AKI). We hypothesise that CKRT technical parameters and treatment settings in addition to the clinical characteristics of patients may influence the circuit lifetime in children. METHODS: The study involved children included in the EurAKId registry (NCT02960867), who underwent CKRT treatment. We analysed patient characteristics and CKRT parameters. The primary end point was mean circuit lifetime (MCL). Secondary end points were number of elective circuit changes and occurrence of dialysis-related complications. RESULTS: The analysis was composed of 247 children who underwent 37,562 h of CKRT (median 78, IQR 37-165 h per patient). A total of 1357 circuits were utilised (3, IQR 2-6 per patient). MCL was longer in regional citrate anticoagulation (RCA), compared to heparin (HA) and no anticoagulation (NA) (42, IQR 32-58 h; 24, IQR 14-34 h; 18, IQR 12-24 h, respectively, p < 0.001). RCA was associated with longer MCL regardless of the patient's age or dialyser surface. In multivariate analysis, MCL correlated with dialyser surface area (beta = 0.14, p = 0.016), left internal jugular vein vascular access site (beta = -0.37, p = 0.027), and the use of HA (beta = -0.14, p = 0.038) or NA (beta = -0.37, p < 0.001) vs. RCA. RCA was associated with the highest ratio of elective circuit changes and the lowest incidence of complications. CONCLUSION: Anticoagulation modality, dialyser surface, and vascular access site influence MCL. RCA should be considered when choosing first-line anticoagulation for CKRT in children. Further efforts should focus on developing guidelines and clinical practice recommendations for paediatric CKRT.